About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 74 adults in the European Union trial and 94 adults in the US trial, all with erythropoietic protoporphyria
- Sample size
- 168
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Funded by Clinuvel Pharmaceuticals and others. Two moderate-sized trials with different durations. Registrations NCT01605136 and NCT00979745.
Cited in
Two phase 3 trials in EPP
Afamelanotide · Research finding
ModerateAdverse events in the phase 3 trials
Afamelanotide · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.